Related Experiment Video
Updated: Jan 2, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Microglial V-set and immunoglobulin domain-containing 4 protects against ischemic stroke in mice by suppressing
Qingping Lyu1, Xiaojun Pang1, Zibin Zhang1
1Department of Neurosurgery, Hangzhou Red Cross Hospital/Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, 208 Huancheng Road East, HangZhou 310003, Zhejiang, China.
Abstract:
Ischemic stroke is a leading cause of death among human in the world, and a critical cause for long-term disability. Accumulating studies have indicated that inflammatory response regulated by microglia contributes a lot to neuronal death, but the molecular mechanism still remains unclear. V-set and immunoglobulin domain-containing 4 (Vsig4), a complement receptor of the immunoglobulin superfamily (CRIg) that specifically expresses in resting tissue-resident macrophages, plays a critical role in regulating various inflammatory diseases via multiple signaling pathways. However, the effects of Vsig4 on ischemic stroke have not been investigated. In this study, we identified that Vsig4 expression was decreased after cerebral ischemic injury induced by middle cerebral artery occlusion (MCAO). Immunofluorescence staining showed that Vsig4 was co-localized with Iba1 in microglial cells from the infarct region of MCAO-operated mice. After over-expressing Vsig4 in mice, MCAO-induced infarction area and neurological deficits score were markedly attenuated. In addition, neurological dysfunction due to MCAO surgery was improved by Vsig4 over-expression. Microglial M1 polarization was detected in mice with MCAO surgery, which was markedly inhibited by Vsig4 over-expression, as evidenced by the markedly reduced expression of CD16, CD11b, inducible nitric oxide synthase (iNOS) and interleukin 6 (IL-6); however, the expression of M2-like phenotype hallmarks such as arginase 1 (Arg1), CD206, IL-10 and Ym-1 was significantly up-regulated. Mechanistically, the anti-inflammatory role of Vsig4 was mainly through the blockage of toll-like receptor 4/nuclear factor kappa B (TLR4/NF-κB) signaling via the in vivo and in vitro experiments. Also, we found that microglial TLR4 expression in the cerebral infarct area of MCAO mice was highly suppressed by Vsig4 over-expression. In vitro, the neuron-glial mixed culture by fluorescent staining showed that oxygen glucose deprivation (OGD) treatment led to significant cell death, while being attenuated by Vsig4 over-expression in primary microglial cells. Finally, we showed that Vsig4 could interact with TLR4 and repress its expression, subsequently alleviating ischemic stroke. Collectively, our findings demonstrated that microglial Vsig4 protected against post-stroke neuro-inflammation mainly through interacting with TLR4.
Insights
V-set and immunoglobulin domain-containing 4 (Vsig4) protein reduces brain damage after ischemic stroke by inhibiting neuroinflammation. Overexpressing Vsig4 in mice decreased stroke severity and improved neurological function by blocking the TLR4/NF-κB pathway.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Ischemic stroke is a major cause of death and disability worldwide.
- Microglia-mediated inflammatory responses contribute to neuronal death after stroke, but mechanisms are unclear.
- V-set and immunoglobulin domain-containing 4 (Vsig4) regulates inflammatory diseases but its role in ischemic stroke is unknown.
Purpose of the Study:
- To investigate the role of Vsig4 in ischemic stroke.
- To elucidate the molecular mechanisms by which Vsig4 affects neuroinflammation and stroke outcomes.
Main Methods:
- Middle cerebral artery occlusion (MCAO) model in mice to induce ischemic stroke.
- Vsig4 over-expression in mice and in vitro microglial cell cultures.
- Immunofluorescence staining for Vsig4, Iba1, and microglial markers (M1/M2 phenotypes).
- Analysis of TLR4/NF-κB signaling pathway activation.
- Oxygen-glucose deprivation (OGD) assay in primary microglial cells.
Main Results:
- Vsig4 expression decreased in the infarct region after MCAO.
- Vsig4 over-expression reduced infarct volume and neurological deficits in MCAO mice.
- Vsig4 suppressed M1 microglial polarization and promoted M2 polarization.
- Vsig4 inhibited the TLR4/NF-κB signaling pathway and reduced microglial TLR4 expression.
- Vsig4 over-expression protected primary microglia against OGD-induced cell death.
Conclusions:
- Microglial Vsig4 plays a protective role against ischemic stroke.
- Vsig4 alleviates post-stroke neuroinflammation by interacting with and repressing TLR4 expression.
- Targeting Vsig4 may offer a novel therapeutic strategy for ischemic stroke.

